In silico studies on recreational drugs: 3D quantitative structure activity relationship prediction of classified and de novo designer benzodiazepines
- PMID: 35838189
- DOI: 10.1111/cbdd.14119
In silico studies on recreational drugs: 3D quantitative structure activity relationship prediction of classified and de novo designer benzodiazepines
Abstract
Currently, increasing availability and popularity of designer benzodiazepines (DBZDs) constitutes a primary threat to public health. To assess this threat, the biological activity/potency of DBZDs was investigated using in silico studies. Specific Quantitative Structure Activity Relationship (QSAR) models were developed in Forge™ for the prediction of biological activity (IC50 ) on the γ-aminobutyric acid A receptor (GABA-AR) of previously identified classified and unclassified DBDZs. A set of new potential ligands resulting from scaffold hopping studies conducted with MOE® was also evaluated. Two generated QSAR models (i.e. 3D-field QSAR and RVM) returned very good performance statistics (r2 = 0.98 [both] and q2 = 0.75 and 0.72, respectively). The DBZDs predicted to be the most active were flubrotizolam, clonazolam, pynazolam and flucotizolam, consistently with what reported in literature and/or drug discussion fora. The scaffold hopping studies strongly suggest that replacement of the pendant phenyl moiety with a five-membered ring could increase biological activity and highlight the existence of a still unexplored chemical space for DBZDs. QSAR could be of use as a preliminary risk assessment model for (newly) identified DBZDs, as well as scaffold hopping for the creation of computational libraries that could be used by regulatory bodies as support tools for scheduling procedures.
Keywords: 3D-QSAR; Forge™; MOE®; MedChem; designer benzodiazepines; recreational drugs; scaffold replacement.
© 2022 John Wiley & Sons Ltd.
Similar articles
-
The Psychonauts' Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity.Pharmaceuticals (Basel). 2021 Jul 26;14(8):720. doi: 10.3390/ph14080720. Pharmaceuticals (Basel). 2021. PMID: 34451817 Free PMC article.
-
Designer Benzodiazepines' Activity on Opioid Receptors: A Docking Study.Curr Pharm Des. 2022;28(32):2639-2652. doi: 10.2174/1381612828666220510153319. Curr Pharm Des. 2022. PMID: 35538798
-
Designer Benzodiazepines: Effects, Toxicity, and Interactions.Ther Drug Monit. 2023 Aug 1;45(4):494-507. doi: 10.1097/FTD.0000000000001071. Epub 2023 Jan 27. Ther Drug Monit. 2023. PMID: 36750450 Review.
-
The blood-to-plasma ratio and predicted GABAA-binding affinity of designer benzodiazepines.Forensic Toxicol. 2022 Jul;40(2):349-356. doi: 10.1007/s11419-022-00616-y. Epub 2022 Mar 16. Forensic Toxicol. 2022. PMID: 36454409 Free PMC article.
-
The Evolution Toward Designer Benzodiazepines in Drug-Facilitated Sexual Assault Cases.J Anal Toxicol. 2023 Feb 21;47(1):1-25. doi: 10.1093/jat/bkac017. J Anal Toxicol. 2023. PMID: 35294022 Free PMC article. Review.
Cited by
-
Applications and Potential of In Silico Approaches for Psychedelic Chemistry.Molecules. 2023 Aug 9;28(16):5966. doi: 10.3390/molecules28165966. Molecules. 2023. PMID: 37630218 Free PMC article. Review.
-
Exploring the Metabolism of Flubrotizolam, a Potent Thieno-Triazolo Diazepine, Using Human Hepatocytes and High-Resolution Mass Spectrometry.Metabolites. 2024 Sep 19;14(9):506. doi: 10.3390/metabo14090506. Metabolites. 2024. PMID: 39330513 Free PMC article.
References
REFERENCES
-
- ACMD. (2020a). Addendum to ACMD's report on novel benzodiazepines. Retrieved January 31, 2022, from https://www.gov.uk/government/publications/novel-benzodiazepines-prevale...
-
- ACMD. (2020b). Novel benzodiazepines a review of the evidence of use and harms of novel benzodiazepines. Retrieved from https://www.gov.uk
-
- Alam, S., & Khan, F. (2017). 3D-QSAR studies on Maslinic acid analogs for anticancer activity against breast cancer cell line MCF-7. Scientific Reports, 7(1), 6019. https://doi.org/10.1038/S41598-017-06131-0
-
- Amundarain, M. J., Caffarena, E. R., & Costabel, M. D. (2021). How does α1Histidine102 affect the binding of modulators to α1β2γ2 GABAA receptors? Molecular insights from in silico experiments. Physical Chemistry Chemical Physics, 23(6), 3993-4006. https://doi.org/10.1039/D0CP05081D
-
- Artemenko, A. G., Kuz'Min, V. E., Muratov, E. N., Polishchuk, P. G., Borisyuk, I. Y., & Golovenko, N. Y. (2009). Influence of the structure of substituted benzodiazepines on their pharmacokinetic properties. Pharmaceutical Chemistry Journal, 43(8), 454-462. https://doi.org/10.1007/s11094-009-0332-x
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials